The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of WNT inhibitor ipafricept (IPA) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (mPC).
 
Efrat Dotan
Consulting or Advisory Role - ARMO BioSciences; Boston Biomedical
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Dana Backlund Cardin
Consulting or Advisory Role - Merrimack; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Oncolytics (Inst); Roche (Inst); Synta (Inst)
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Wells A. Messersmith
Consulting or Advisory Role - Gilead Sciences; Purdue Pharma; Tanabe Research
Research Funding - Aduro Biotech; Alexo Therapeutics; Immunomedics; OncoMed; Pfizer; Roche/Genentech; Takeda
 
Bert O'Neil
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; Merck
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Bayer; Merck KGaA
 
Steven J. Cohen
Consulting or Advisory Role - Amgen; Bayer; Celgene; Genentech; Taiho Pharmaceutical
 
Crystal S. Denlinger
Consulting or Advisory Role - Bristol-Myers Squibb; Carevive Systems; EMD Serono; Lilly; Merck
Research Funding - Advaxis (Inst); Agios (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst)
 
Safi Shahda
Consulting or Advisory Role - AstraZeneca; Bayer; Merrimack
Research Funding - Myriad Genetics
 
Ann M. Kapoun
Employment - OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - OncoMed
Patents, Royalties, Other Intellectual Property - co-author of patents filed at OncoMed (Inst)
Travel, Accommodations, Expenses - OncoMed
 
Rainer Karl Brachmann
Employment - Gilead Sciences (I); OncoMed
Leadership - OncoMed
Stock and Other Ownership Interests - Gilead Sciences (I); OncoMed
 
Shailaja Uttamsingh
Employment - Celgene; OncoMed
Stock and Other Ownership Interests - Celgene; OncoMed
 
Colin D. Weekes
Honoraria - Celgene; Lilly; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Abbvie; Bayer; Celgene; Genentech/Roche; Lilly; Millennium